Clinical Trial Results: VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for VGX-3100 with electroporation in HIV-positive patients with high-grade anal lesions show outcomes after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia
• High Grade Anal Intraepithelial Neoplasia

Drugs mentioned

• VGX-3100

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Anal Intraepithelial Neoplasia, High Grade Squamous Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED | Results posted: 2026-04-29